Moderna (MRNA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist

140.030
-5.200-3.58%

Close Jun 14 16:00 ET

140.000
-0.030-0.02%

Post 19:59 ET

53.67BMarket Cap-8982P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Worried You Missed the Nvidia Bandwagon? Here -2-
AMD is an example of a large company on the list that is expected to grow sales at a rapid clip through 2026, with a P/E that is lower than Nvidia's. AMD's P/E is also a bit lower than it was a year a
MarketWatchJun 15 07:00 ET
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Yahoo FinanceJun 15 01:54 ET
Moderna(MRNA.US) Director Sells US$2.21 Million in Common Stock
$Moderna(MRNA.US)$ Director AFEYAN NOUBAR sold 15,000 shares of common stock on Jun 12, 2024 at an average price of $147.2048 for a total value of $2.21 million.Source: Announcement What is statement
moomoo NewsJun 14 19:43 ET
Moderna Stock Traded in the Red for Seven Straight Days
Seeking AlphaJun 14 15:21 ET
Express News | FDA Says On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula): If Feasible Use KP.2 Strain Of JN.1-Lineage
BenzingaJun 14 14:13 ET
CDC 'Preparing for the Possibility' Bird Flu Could Spread More Easily
Seeking AlphaJun 14 10:59 ET

Comments

Jerry Kronenberg

Jun 5 14:52

ColumnsNovavax Rallies Another 25% Intraday as FDA Considers New Vaccines for COVID-19 JN.1 Variant

$Novavax(NVAX.US)$ rallied 20%+ Wednesday for the second time in the past three sessions as a U.S. Food and Drug Administration panel met to consider recommending a new COVID-19 vaccine for the disease's JN.1 variant.
NVAX gained as much as 25.2% to a $22.24 intraday high Wednesday, taking the stock up 48% since last Friday's May 31 close.
The stock rose as the FDA's Vaccines and Related Biological Produc...

Jerry Kronenberg

Jun 3 15:49

ColumnsNovavax Rallies 20%+ on Report FDA Might Soon Recommend New COVID Vaccine for JN.1 Variant

$Novavax(NVAX.US)$ soared more than 20% Monday on a report that the U.S. Food and Drug Administration is considering recommending a new COVID-19 vaccine for the disease's JN.1 variant – a product that NVAX reportedly specializes in.
Novavax rose 21.2% to close at an 18-month high of $18.22 after Yahoo Finance reported that the FDA might soon recommend a JN.1 variant vaccine. The rally took NVAX to its highe...

Moomoo Recap US

Jun 3 15:20

ColumnsNasdaq, S&P Buoyed by Nvidia; Dow Slips | Wall Street Today

by Luzi Ann Santos
US stocks were mixed, with the $Dow Jones Industrial Average(.DJI.US)$ weighed down by weak manufacturing data, while the $S&P 500 Index(.SPX.US)$ and $Nasdaq Composite Index(.IXIC.US)$ got a boost from gains in $NVIDIA(NVDA.US)$.
Trading in some of the stocks, including $Berkshire Hathaway-A(BRK.A.US)$ were temporarily halted before 10 a.m. Monday in New York after a technical glitch that sent shares in the compan...

Luzi Ann Santos

Jun 3 14:36

ColumnsDow Slips Amid Weak Manufacturing Data While Nvidia Buoys Nasdaq, S&P 500

US stocks were mixed, with the $Dow Jones Industrial Average(.DJI.US)$ weighed down by weak manufacturing data, while the $Nasdaq Composite Index(.IXIC.US)$ and the $S&P 500 Index(.SPX.US)$ got a boost from gains in $NVIDIA(NVDA.US)$.
Trading in some of the stocks, including $Berkshire Hathaway-A(BRK.A.US)$ were temporarily halted before 10 a.m. Monday in New York after a technical glitch that sent shares in the company led...